{"text": "gild below avg volume daily appearances since 2010 419 close 5 days later avg 0 17 sd 2 34 worst 14 50 best 9 96 10 days later avg 0 24 sd 3 25 worst 15 57 best 11 64 30 days later avg 0 23 sd 5 09 worst 20 80 best 11 41"}
{"text": "tsoi therapeutic solutions engages venvalo group to assist in regulatory strategic amp implementation aspects of recently fda cleared phase iii clinical trial of jadicells to treat patients with advanced covid 19 pfe mrna enzc intc mrk gild jnj"}
{"text": "sp100 us s amp p 100 index top brk b biib intc gild selected by our stock screener stocks valueinvesting valuation"}
{"text": "very nice update from dffn today incl co seeing having enough funds for clinical trials operating needs through 23 we added more to this potential global oxygenate therapy name ibb xbi pfe mrna jnj nvax mrk gild"}
{"text": "rbc gild pfe s recent tril acquisition has renewed attention to cd47 space expect 2h21 data to support the potential of gild s magrolimab in mds and other indications and that despite being a first gen molecule magrolimab compares favorably to other cd47 targeting approaches"}
{"text": "atrx laboratory and clinical research support mlr 1023 as the worlds first safe effective beta cell proliferative agent ibb nvs jnj pfe gild amgn bsx"}
